TY  - BOOK
AU  - Fisher,Gary L.
AU  - Roget,Nancy A.
TI  - Encyclopedia of substance abuse prevention, treatment, & recovery
SN  - 9781412950848
U1  - 362.2903 22
PY  - 2009///
CY  - Los Angeles
PB  - SAGE
KW  - Substance abuse
KW  - Encyclopedias
KW  - Substance-Related Disorders
N1  - "A SAGE reference publication."; Includes bibliographical references and index; v. 1 --; List of entries --; Reader's guide --; About the editors --; Contributors --; Introduction --; Entries --; v. 2 --; List of entries --; Reader's guide --; Entries --; Appendix : Entries related to specific drugs --; Index; Abstinence --; Abstinence violation effect --; Acamprosate --; Acceptance and commitment therapy --; Access to recovery --; Addiction, models of --; Addiction severity index --; Addiction technology transfer centers --; Adolescents, substance abuse and treatment --; Adult children of alcoholics --; African Americans, issues in prevention and treatment --; Aftercare --; Al-Anon --; Alateen --; Alcohol --; Alcoholic personality --; Alcoholics Anonymous --; Alcohol-induced disorders --; Alcoholism --; Alcohol marketing --; Alcohol-related birth defects --; Alcohol testing --; Alcohol Use Disorders Identification Test --; Alternative activities --; American Society of Addiction Medicine --; Amotivational syndrome --; Amphetamines --; Amyl nitrite --; Anabolic steroids --; Anorexia nervosa --; Antabuse (disulfiram) --; Antianxiety agents --; Antidepressant drugs --; Antipsychotic drugs --; Antiseizure drugs --; Antisocial personality disorder --; Anxiety disorders --; Anxiolytic drugs --; Asian Americans/Pacific Islanders, issues in prevention and treatment --; Assessment --; Assessment instruments --; Athletes and drug use --; Attention deficit hyperactivity disorder --; Aversive conditioning --; Aversive therapy --; Barbiturates --; Behavioral couples therapy --; Behavior risk factor surveillance system --; Behavioral therapy --; Benzodiazephines --; Biculturalism --; Big book, the --; Bill W. --; Binge drinking --; Biopsychosocial model of addiction --; Blood alcohol concentration --; Borderline personality disorder --; Brain chemistry and addiction --; Brief interventions --; Brief strategic family therapy --; Bulimia nervosa --; Buprenorphine --; Business improvement practices --; Caffeine --; CAGE screening instrument --; Cannabinols --; Cannabis youth treatment study --; CENAPS model --; Center for Substance Abuse Prevention --; Center for Substance Abuse Treatment --; Centers for the Application of Prevention Technologies --; Central nervous system depressants --; Central nervous system stimulants --; Certification and licensing --; Chemical dependency --; Children of alcoholics --; Chronicity --; Client engagement --; Client/treatment matching --; Clinical supervision of addiction counselors --; Club drugs --; Coalcoholic --; Cocaine and crack --; Cocaine Anonymous --; Codependency --; Coercion and treatment --; Cognitive behavioral therapy --; Cognitive-social learning model --; College on Problems of Drug Dependence --; College students, alcohol use and abuse --; College students, drug use and abuse --; COMBINE study --; Community-based processes --; Community reinforcement and family training --; Community reinforcement approach --; Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513) --; Confidentiality --; Contingency management --; Continuum of care --; Co-occurring disorders --; Counseling approaches --; Court-mandated treatment --; Covert sensitization --; Crack --; Craving --; Crime and substance abuse --; Criminal justice populations --; Cross-addictions --; Cultural aspects --; Decriminalization --; Demand reduction --; Denial --; Depression --; Detoxification --; Diagnosis --; Diagnostic and Statistical Manual of Mental Disorders --; Disabilities, issues in prevention and treatment --; Discrimination, addicted and recovering individuals --; Disease concept --; Double trouble --; Driving under the influence --; Driving while intoxicated --; Drug abuse --; Drug abuse resistance education --; Drug abuse screening test --; Drug abuse treatment outcome studies --; Drug abuse warning network --; Drug addiction --; Drug courts --; Drug-crime cycle --; Drug-free Schools and Communities Act --; Drug laws, history of --; Drugs, classification of --; Drug testing --; Drug use, history of --; Dry drunk syndrome --; Dual relationships --; Eating disorders --; Economic costs of alcohol and drug abuse --; Ecstasy --; Elderly populations, treatment issues --; Electronic health records --; Empirically based prevention --; Empirically based treatment --; Employee Assistance Program --; Enabling --; Environmental approaches --; Ethical standards for addiction professionals --; Ethics --; Evidence-based prevention --; Evidence-based prevention and treatment, dissemination and adoption of --; Evidence-based treatment --; Expectancies --; Experimental substance use --; Family behavior therapy --; Family counseling --; Family therapy --; Fentanyl --; Fetal alcohol syndrome --; Fetal effects of alcohol and other drugs --; Fidelity of prevention programs --; Gamblers Anonymous --; Gambling, pathological --; Gambling, problem --; Gateway drugs theory --; Gay, lesbian, bisexual, and transgender issues --; Gender issues --; Genetic aspects of addiction --; Grief, loss, and substance abuse --; Group therapy and counseling --; Hallucinogens --; Harm reduction, public health --; Harm reduction psychotherapy --; Hashish --; Health care system and substance abuse --; Health Insurance Portability and Accountability Act --; Hepatitis C --; Heroin --; High-risk behaviors --; High-risk situations --; Hispanics/Latinos, issues in prevention and treatment --; HIV/AIDS --; Homeless, substance abuse and treatment --; Issues in prevention ; racial and ethnic minorities --; Issues in treatment --; Ice --; Illicit and illegal drugs --; Impaired professionals --; Indian health services --; Information dissemination --; Informed consent --; Inhalants --; Injection drug use --; Inpatient treatment --; Institute of Medicine Classification System --; International Coalition for Addiction Studies Education --; Internet addiction --; Intervention --; Intravenous drug use --; Inventory of drinking situations --; Jellinek, E.M. --; Johnson model intervention ---; Join Together --; Legal Action Center --; Legalization of drugs --; Levo-alpha acetyl methadol --; Marijuana --; Maternal drug use --; Matrix model --; Media campaigns --; Medical consequences --; Medical use of marijuana --; Mentoring --; Methadone --; Methadone maintenance treatment --; Methamphetamine --; Methods of drug administration --; Michigan Alcohol Screening Test --; Minnesota model --; Moderation approaches to alcohol problems --; Moderation in use --; Moderation management --; Monitoring the future --; Moral model --; Morphine --; Motivational enhancement therapy --; Motivational interviewing --; Multiculturalism --; Multidimensional family therapy --; NAADAC, the Association for Addiction Professionals --; Naloxone --; Naltrexone --; Narcotics Anonymous --; National Clearinghouse for Alcohol and Drug Information --; National Council on Alcoholism and Drug Dependence --; National Council on Problem Gambling --; National Drug Control Strategy --; National Epidemiologic Survey on Alcohol and Related Conditions --; National Gambling Impact Study Commission --; National Institute of Mental Health --; National Institute on Alcohol Abuse and Alcoholism --; National Institute on Drug Abuse --; National Institute on Drug Abuse Clinical Trials Network --; National media campaign --; National outcome measures --; National Registry of Evidence-based Programs and Practices --; National Survey on Drug Use and Health --; National Treatment Improvement Evaluation Study --; Native Americans, issues in prevention and treatment --; Natural recovery --; Needle exchange programs --; Network for the improvement of addiction treatment --; Neurobiology of addiction --; Neurocognitive effects of alcohol and other drugs --; Neurotransmitters --; Nicotine --; Nicotine replacement therapy --; Office of National Drug Control Policy --; Opiates --; Opioids --; Other addictions --; Outpatient treatment --; Over-the-counter drugs --; OxyContin --; Pain management --; Patient placement criteria --; Peer recovery support services --; Pharmacological approaches to treatment --; Physiological aspects of drug use --; Post-traumatic stress disorder --; Prescription drugs --; Prevention education --; Prevention evaluation --; Prevention populations --; Prevention programs --; Prevention strategies --; Problem identification and referral --; Problem oriented screening instrument for teenagers --; Project MATCH --; Psychological models of addiction --; Psychosocial history --; Public policy, alcohol --; Public policy, drugs --; Public policy, prevention --; Public policy, treatment --; Pulse check --; Qualified services organization agreements --; Racial and ethnic minorities, issues in alcohol and other drug use --; Racial and ethnic minorities, issues in prevention --; Rapid opioid detoxification --; Rational recovery --; Recovery --; Recovery community organizations --; Recovery community services program --; Recovery schools --; Recovery support services --; Refusal skills --; Relapse --; Relapse prevention --; Research issues in prevention --; Research issues in treatment --; Residential treatment --; Resistance in treatment --; Reverse tolerance --; Risk and protective factor theory --; Risk factors for addiction --; Routes of administration of drugs --; School-based prevention programs --; School drug policies --; Scope of practice --; Screening --; Screening instruments --; Secular organizations for sobriety/Save Our Selves --; Sedative-hypnotics --; Self-change --; Self-help groups --; Self-report inventories --; Sex addiction --; Sexually transmitted diseases --; Shopping addiction --; Single state authorities --; Sobriety --; Social drinking --; Social learning model of addictive behaviors --; Social norms marketing --; Social skills training --; Sociocultural models of addiction --; Solution-focused therapy --; Special populations --; Spiritual issues --; Spontaneous remission --; Stages of change model --; State provider associations --; STD --; Steroids --; Stigma --; Student assistance program --; Substance abuse --; Substance abuse and mental health services administration --; Substance abuse subtle screening inventory-3 --; Substance dependence --; Substance-induced disorders --; Substance-induced withdrawal delirium --; Substance use disorders --; Substitute addictions --; Suicide --; Supply reduction --; Support groups --; Synanon --; Synar amendment --; Therapeutic communities --; Timeline followback --; Tobacco --; Tobacco cessation programs and treatments --; Tobacco marketing and countermarketing --; Tobacco master settlement agreement --; Tolerance --; Treatment, history of --; Treatment, nontraditional approaches --; Treatment access and retention --; Treatment approaches and strategies --; Treatment effectiveness --; Treatment facilities --; Treatment in jails and prisons --; Treatment of alcohol and drug use disorders --; Treatment plans and treatment planning --; Treatment programs for alcohol or drug abuse --; Treatment settings --; Tuberculosis --; Twelve-step facilitation --; Twelve-step recovery programs --; Twelve steps --; Underage drinking --; Urine toxicology testing --; Veterans, substance abuse and treatment --; Violence, intimate partner and substance abuse treatment --; Violence prevention --; War on drugs --; Welfare reform and substance abuse --; Willpower --; Withdrawal --; Women for sobriety --; Womens' issues in prevention and treatment --; Workplace drug policies --; Workplace drug use --; Workplace prevention
UR  - http://wallaby.vu.edu.au:2048/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xww&AN=474383
ER  -